Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 401/00 (2006.01) A61K 31/593 (2006.01) A61P 3/14 (2006.01)

Patent

CA 2463505

The present invention provides novel 16-ene-C25-oxime and 16-ene-C-25-oxime ether analogs of 1.alpha.,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compound of Formula I are useful for treating diseases which benefit from a modulation of the levels of 1.alpha.,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.

La présente invention concerne des nouveaux analogues éther 16-ene-C25-oxime et 16-ene-C-25-oxime de 1.alpha.,25-dihydroxy vitamine D¿3?, des compositions comprenant ces composés et des méthodes permettant d'utiliser ces composés en tant qu'inhibiteurs de CYP24. En particulier, le composé représenté par la formule I est utilisé pour traiter des maladies bénéficiant d'une modulation des niveaux de 1.alpha.,25-dihydroxy vitamine D¿3?, par exemple, des troubles de prolifération cellulaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1850611

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.